Trial
NCT02030184
Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Small Cell Lung Cancer (SCLC)
Intervention
Rhenium Re 188-P2045
Why stopped
PI has left the study institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-17